1. Home
  2. FEDU vs SABS Comparison

FEDU vs SABS Comparison

Compare FEDU & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEDU
  • SABS
  • Stock Information
  • Founded
  • FEDU 2007
  • SABS 2014
  • Country
  • FEDU China
  • SABS United States
  • Employees
  • FEDU N/A
  • SABS N/A
  • Industry
  • FEDU
  • SABS Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEDU
  • SABS Health Care
  • Exchange
  • FEDU NYSE
  • SABS Nasdaq
  • Market Cap
  • FEDU 20.0M
  • SABS 19.0M
  • IPO Year
  • FEDU 2017
  • SABS N/A
  • Fundamental
  • Price
  • FEDU $9.95
  • SABS $1.20
  • Analyst Decision
  • FEDU
  • SABS Strong Buy
  • Analyst Count
  • FEDU 0
  • SABS 5
  • Target Price
  • FEDU N/A
  • SABS $11.40
  • AVG Volume (30 Days)
  • FEDU 4.4K
  • SABS 37.2K
  • Earning Date
  • FEDU 12-20-2024
  • SABS 05-19-2025
  • Dividend Yield
  • FEDU 23.50%
  • SABS N/A
  • EPS Growth
  • FEDU N/A
  • SABS N/A
  • EPS
  • FEDU 0.12
  • SABS N/A
  • Revenue
  • FEDU $27,971,139.00
  • SABS $1,322,410.00
  • Revenue This Year
  • FEDU N/A
  • SABS N/A
  • Revenue Next Year
  • FEDU N/A
  • SABS $25.00
  • P/E Ratio
  • FEDU $83.99
  • SABS N/A
  • Revenue Growth
  • FEDU 141.14
  • SABS N/A
  • 52 Week Low
  • FEDU $7.41
  • SABS $1.11
  • 52 Week High
  • FEDU $22.70
  • SABS $5.01
  • Technical
  • Relative Strength Index (RSI)
  • FEDU 55.98
  • SABS 33.63
  • Support Level
  • FEDU $8.78
  • SABS $1.53
  • Resistance Level
  • FEDU $9.90
  • SABS $1.80
  • Average True Range (ATR)
  • FEDU 0.33
  • SABS 0.15
  • MACD
  • FEDU 0.10
  • SABS 0.02
  • Stochastic Oscillator
  • FEDU 93.18
  • SABS 0.00

About FEDU FOUR SEASONS EDUCATION (CAYMAN) INC SPON ADS EACH REP 10 ORD SHS(R/S)

Four Seasons Education (Cayman) Inc is engaged in the provision of after-school education services for kindergarten, elementary and middle school students. The Company derives its revenue from learning services, tourism services, and learning technology and content solutions. The company is a comprehensive educational enterprise that provides research practice services, educational informatization equipment, high-quality educational resources, and teacher training, as well as a digital publishing business, and continues to expand in educational research and educational informatization.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: